Comparative Pharmacology
Head-to-head clinical analysis: DECA DURABOLIN versus NANDROLONE PHENPROPIONATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DECA DURABOLIN versus NANDROLONE PHENPROPIONATE.
DECA-DURABOLIN vs NANDROLONE PHENPROPIONATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nandrolone decanoate is an anabolic steroid that binds to androgen receptors, increasing protein synthesis and promoting muscle growth. It also stimulates erythropoietin production, increasing red blood cell mass.
Nandrolone phenpropionate is an anabolic steroid that binds to androgen receptors, activating gene expression leading to increased protein synthesis, nitrogen retention, and muscle growth. It also exhibits weak androgenic activity and may inhibit glucocorticoid receptors.
Intramuscular injection of 100-200 mg every 1-3 weeks for anabolic effects; for replacement therapy, 50-100 mg every 2-4 weeks.
100-200 mg intramuscularly every 2-3 weeks.
None Documented
None Documented
Terminal half-life of nandrolone decanoate is 4.3 hours for the decanoate ester, but the active metabolite nandrolone has a prolonged half-life of 6-7 days due to slow release from intramuscular depot and enterohepatic recirculation; clinical effects persist for 3-4 weeks.
Terminal elimination half-life approximately 8-10 hours, but active metabolite 19-nortestosterone has a longer half-life (~2-4 hours), necessitating frequent dosing for stable blood levels.
Primarily renal (90% as metabolites, 5% unchanged); fecal elimination accounts for <5%.
Primarily renal (90% as metabolites, mainly glucuronide and sulfate conjugates; 6% as unchanged drug); about 4% fecal.
Category C
Category C
Anabolic Steroid
Anabolic Steroid